BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22891161)

  • 1. Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistance.
    Chakrabarti L; Abou-Antoun T; Vukmanovic S; Sandler AD
    Front Oncol; 2012; 2():82. PubMed ID: 22891161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance.
    Abou-Antoun TJ; Nazarian J; Ghanem A; Vukmanovic S; Sandler AD
    PLoS One; 2018; 13(1):e0189711. PubMed ID: 29298329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism linking Id2-TGFβ crosstalk to reversible adaptive plasticity in neuroblastoma.
    Chakrabarti L; Wang BD; Lee NH; Sandler AD
    PLoS One; 2013; 8(12):e83521. PubMed ID: 24376712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
    Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
    Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic Switching and Filamentation in Candida haemulonii, an Emerging Opportunistic Pathogen of Humans.
    Deng Y; Li S; Bing J; Liao W; Tao L
    Microbiol Spectr; 2021 Dec; 9(3):e0077921. PubMed ID: 34878301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic Propensities.
    Philipp LM; Yesilyurt UU; Surrow A; Künstner A; Mehdorn AS; Hauser C; Gundlach JP; Will O; Hoffmann P; Stahmer L; Franzenburg S; Knaack H; Schumacher U; Busch H; Sebens S
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.
    Axelson H; Fredlund E; Ovenberger M; Landberg G; Påhlman S
    Semin Cell Dev Biol; 2005; 16(4-5):554-63. PubMed ID: 16144692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
    Hsu DM; Agarwal S; Benham A; Coarfa C; Trahan DN; Chen Z; Stowers PN; Courtney AN; Lakoma A; Barbieri E; Metelitsa LS; Gunaratne P; Kim ES; Shohet JM
    Cancer Res; 2013 Jul; 73(13):4134-46. PubMed ID: 23687340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas.
    Navas T; Kinders RJ; Lawrence SM; Ferry-Galow KV; Borgel S; Hollingshead MG; Srivastava AK; Alcoser SY; Makhlouf HR; Chuaqui R; Wilsker DF; Konaté MM; Miller SB; Voth AR; Chen L; Vilimas T; Subramanian J; Rubinstein L; Kummar S; Chen AP; Bottaro DP; Doroshow JH; Parchment RE
    Cancer Res; 2020 Jan; 80(2):304-318. PubMed ID: 31732654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC.
    Konen JM; Rodriguez BL; Padhye A; Ochieng JK; Gibson L; Diao L; Fowlkes NW; Fradette JJ; Peng DH; Cardnell RJ; Kovacs JJ; Wang J; Byers LA; Gibbons DL
    Cancer Res; 2021 Mar; 81(5):1398-1412. PubMed ID: 33402388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma.
    Sehgal M; Nayak SP; Sahoo S; Somarelli JA; Jolly MK
    Cancer Biol Ther; 2024 Dec; 25(1):2301802. PubMed ID: 38230570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of U251 glioma stem cells and their heterogeneous stem-like phenotypes.
    Zhang S; Xie R; Wan F; Ye F; Guo D; Lei T
    Oncol Lett; 2013 Dec; 6(6):1649-1655. PubMed ID: 24260059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.
    Nozaki K; Kagamu H; Shoji S; Igarashi N; Ohtsubo A; Okajima M; Miura S; Watanabe S; Yoshizawa H; Narita I
    PLoS One; 2014; 9(10):e111019. PubMed ID: 25343452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model.
    Cao D; Kishida S; Huang P; Mu P; Tsubota S; Mizuno M; Kadomatsu K
    PLoS One; 2014; 9(1):e86813. PubMed ID: 24466252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
    Naveen CR; Gaikwad S; Agrawal-Rajput R
    Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
    Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
    Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells.
    Tripathi S; Chakraborty P; Levine H; Jolly MK
    PLoS Comput Biol; 2020 Feb; 16(2):e1007619. PubMed ID: 32040502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.
    Coulon A; Flahaut M; Mühlethaler-Mottet A; Meier R; Liberman J; Balmas-Bourloud K; Nardou K; Yan P; Tercier S; Joseph JM; Sommer L; Gross N
    Neoplasia; 2011 Oct; 13(10):991-1004. PubMed ID: 22028624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity.
    Bernardo MM; Kaplun A; Dzinic SH; Li X; Irish J; Mujagic A; Jakupovic B; Back JB; Van Buren E; Han X; Dean I; Chen YQ; Heath E; Sakr W; Sheng S
    Cancer Res; 2015 Sep; 75(18):3970-9. PubMed ID: 26208903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system (CNS) tumor cell heterogeneity contributes to differential platinum-based response in an in vitro 2D and 3D cell culture approach.
    Gonçalves BÔP; Fialho SL; Silvestrini BR; Sena IFG; Dos Santos GSP; Assis Gomes D; Silva LM
    Exp Mol Pathol; 2020 Oct; 116():104520. PubMed ID: 32828740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.